Top Markets
#1 Black Phoenix Black Phoenix +829.97%
#2 pipedog pipedog +41.42%
#3 PondCoin PondCoin +34.34%
#4 Bless Bless +32.22%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +28.74%
#6 SAFEcoin SAFEcoin +26.51%
#7 Beam Beam +24.69%
#8 Magma Finance Magma Finance +19.36%
#9 Seeker Seeker +19.26%
#10 YFSX YFSX +16.15%
Coin of the day
Black Phoenix Black Phoenix
सेटिंग्स
भाषा
हिन्दी
मुद्रा
USD
थीम
Alpine Immune Sciences, Inc. Alpine Immune Sciences, Inc.

Alpine Immune Sciences, Inc.

ALPN
शेयरों में रैंक #6581
Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company... Alpine Immune Sciences, Inc. is a clinical-stage biopharmaceutical company focused on discovering and advancing protein-based immunotherapies. Their therapeutic endeavors address a range of conditions, including various cancers, autoimmune and inflammatory disorders, among others. The company's pipeline features ALPN-101, an ICOS/CD28 antagonist program being developed for autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor aimed at treating cancer; and ALPN-303, a dual B cell cytokine antagonist for B cell-mediated inflammatory and autoimmune conditions. Alpine Immune Sciences has established strategic collaborations, including an agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101, and a partnership with Adaptimmune Therapeutics plc to create next-generation SPEAR T cell products. The company was founded in 2007 and operates from its headquarters in Seattle, Washington.
शेयर मूल्य
$64.97
अंतिम समन्वयन: 2024-05-20
मार्केट कैप
$1.97B
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
0.00%
देश
US
व्यापार Alpine Immune Sciences, Inc. (ALPN)

श्रेणी

Healthcare
Alpine Immune Sciences, Inc. (ALPN) के लिए राजस्व
Mar 2024 में राजस्व TTM: $56.52M
Alpine Immune Sciences, Inc. की नवीनतम वित्तीय रिपोर्टों के अनुसार, कंपनी की वर्तमान राजस्व (TTM) $56.52M है। 2022 में, कंपनी ने $30.06M का राजस्व अर्जित किया जो 2021 के $23.44M के राजस्व से की वृद्धि है। राजस्व वह कुल आय है जो कंपनी अपने उत्पादों या सेवाओं की बिक्री से उत्पन्न करती है। लाभ की तुलना में इसमें कोई खर्च घटाया नहीं जाता।
Alpine Immune Sciences, Inc. के लिए 2012 से 2026 तक की राजस्व इतिहास
प्रत्येक वर्ष के अंत में राजस्व
वर्ष राजस्व परिवर्तन
2026 (TTM) $56.52M -4.00%
2023 $58.88M 95.84%
2022 $30.06M 28.24%
2021 $23.44M 151.13%
2020 $9.34M 436.49%
2019 $1.74M 146.81%
2018 $705.00K -59.27%
2017 $1.73M -41.32%
2016 $2.95M 499.59%
2015 $492.00K 0.00%
2014 0.00 0.00%
2013 0.00 0.00%
2012 0.00 0.00%
समान कंपनियों या प्रतिस्पर्धियों के लिए राजस्व
कंपनी राजस्व राजस्व में अंतर देश
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 22,235.59%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 10,553.19%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B 27,755.71%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 3,841.90%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH